Value £5,260,000

Genedrive

VC Funding

Series A

Healthcare & Biotech Published 9 March 2026

Summary

Genedrive, a Manchester-based pharmacogenetic testing company, has raised £5.26m in new funding to boost commercialisation and expansion aims.

Summary of transaction details:

Value: £5.26m
Sector: Healthcare & Biotech
Advisor: N/A
Key Entities: Genedrive
Location: Manchester

Note: This funding will enable Genedrive to accelerate its commercialisation and expansion plans, solidifying its position in the pharmacogenetic testing market.

Lead Investor / Acquirer

Undisclosed Group

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Antiverse

£7,000,000

Mar 2025

VC Funding

Apposite Healthcare Growth I

£100,000,000

Apr 2026

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

SatVu

£30,000,000

Mar 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.